Market Overview

Allergan Q3 Earnings Preview


On Tuesday, November 5, Allergan (NYSE: AGN) will release its latest earnings report. Benzinga's outlook for Allergan is included in the following report.

Earnings and Revenue

Allergan EPS will likely be near $4.22 while revenue will be around $3.88 billion, according to analysts.

In the same quarter last year, Allergan reported EPS of $4.25 on revenue of $3.91 billion. If the company were to match the consensus estimate when it reports Tuesday, earnings would be down 0.71%. Revenue would have fallen 0.79% from the same quarter last year. Allergan's reported EPS has stacked up against analyst estimates in the past like this:


Quarter Q2 2019 Q1 2019 Q4 2018 Q3 2018
EPS Estimate 4.340 3.550 4.15 4.02
EPS Actual 4.380 3.790 4.29 4.25

Stock Performance

Over the last 52-week period, shares are up 8.41%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release. Analysts have adjusted their estimates lower for EPS and revenues over the past 90 days. The most common rating from analysts on Allergan stock is a Neutral. The strength of this rating has maintained conviction over the past three months.

Conference Call

Allergan is scheduled to hold a conference call at 8:00 a.m. ET and it can be accessed here:

Posted-In: Earnings News


Related Articles (AGN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at